title: Does the AToMIC trial explode concerns of contrast coagulopathy?
authors.affiliation: Division of Cardiology, Department of Medicine, Veterans Affairs Long Beach Medical Center, University of California, Irvine Medical Center, Orange, California.
authors.forename: Arnold H
authors.initials: AH
authors.lastname: Seto
authors.affiliation: Division of Cardiology, Department of Medicine, Veterans Affairs Long Beach Medical Center, University of California, Irvine Medical Center, Orange, California.
authors.forename: Morton J
authors.initials: MJ
authors.lastname: Kern
mesh_terms: D015415:Biomarkers / Q000097:blood; D003287:Contrast Media / Q000494:pharmacology; D017023:Coronary Angiography / Q000379:methods*; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000601:surgery; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D007485:Ioxaglic Acid / Q000494:pharmacology*; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D013927:Thrombosis / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D014283:Triiodobenzoic Acids / Q000494:pharmacology*
chemical_list: D015415:Biomarkers; D003287:Contrast Media; D014283:Triiodobenzoic Acids; C044834:iodixanol; D007485:Ioxaglic Acid